X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA MERCK LTD PLETHICO PHARMA/
MERCK LTD
 
P/E (TTM) x -1.1 48.9 - View Chart
P/BV x 0.0 6.4 0.3% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 PLETHICO PHARMA   MERCK LTD
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
MERCK LTD
Dec-16
PLETHICO PHARMA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs3951,060 37.3%   
Low Rs31623 5.0%   
Sales per share (Unadj.) Rs604.4632.4 95.6%  
Earnings per share (Unadj.) Rs32.545.7 71.0%  
Cash flow per share (Unadj.) Rs51.362.3 82.4%  
Dividends per share (Unadj.) Rs011.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs473.6388.8 121.8%  
Shares outstanding (eoy) m34.0816.60 205.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.41.3 26.5%   
Avg P/E ratio x6.618.4 35.6%  
P/CF ratio (eoy) x4.213.5 30.7%  
Price / Book Value ratio x0.52.2 20.8%  
Dividend payout %024.1 0.0%   
Avg Mkt Cap Rs m7,26213,969 52.0%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m1,5961,487 107.4%   
Avg. sales/employee Rs ThNM6,631.9-  
Avg. wages/employee Rs ThNM939.2-  
Avg. net profit/employee Rs ThNM479.4-  
INCOME DATA
Net Sales Rs m20,59810,498 196.2%  
Other income Rs m386242 159.4%   
Total revenues Rs m20,98410,741 195.4%   
Gross profit Rs m2,8181,135 248.2%  
Depreciation Rs m642276 233.1%   
Interest Rs m1,5930-   
Profit before tax Rs m9691,102 87.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138343 -40.3%   
Profit after tax Rs m1,107759 145.9%  
Gross profit margin %13.710.8 126.5%  
Effective tax rate %-14.331.1 -45.9%   
Net profit margin %5.47.2 74.3%  
BALANCE SHEET DATA
Current assets Rs m18,8776,410 294.5%   
Current liabilities Rs m11,8968,828 134.8%   
Net working cap to sales %33.9-23.0 -147.1%  
Current ratio x1.60.7 218.6%  
Inventory Days Days3658 62.3%  
Debtors Days Days19838 515.3%  
Net fixed assets Rs m9,8611,406 701.1%   
Share capital Rs m341166 205.2%   
"Free" reserves Rs m12,3316,286 196.2%   
Net worth Rs m16,1396,455 250.0%   
Long term debt Rs m4,7060-   
Total assets Rs m33,1468,828 375.4%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.30-  
Sales to assets ratio x0.61.2 52.3%   
Return on assets %8.18.6 94.8%  
Return on equity %6.911.8 58.3%  
Return on capital %12.317.1 72.0%  
Exports to sales %21.48.3 258.1%   
Imports to sales %15.221.0 72.3%   
Exports (fob) Rs m4,402869 506.4%   
Imports (cif) Rs m3,1362,209 142.0%   
Fx inflow Rs m4,402959 459.2%   
Fx outflow Rs m3,1842,612 121.9%   
Net fx Rs m1,219-1,653 -73.7%   
CASH FLOW
From Operations Rs m2,4371,070 227.7%  
From Investments Rs m-6,265-750 835.6%  
From Financial Activity Rs m2,490-150 -1,662.3%  
Net Cashflow Rs m-1,337171 -782.4%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 4.3 18.2 23.6%  
FIIs % 5.5 1.0 550.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 29.1 25.8%  
Shareholders   10,665 28,591 37.3%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - VENUS REMEDIES COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS